Activating Compound | Comment | Organism | Structure |
---|---|---|---|
ATP | - |
Chlamydia trachomatis | |
DTT | - |
Chlamydia trachomatis | |
additional information | quantitative activation | Chlamydia trachomatis |
Application | Comment | Organism |
---|---|---|
pharmacology | inhibition of RNRs is a proven strategy for combating cancer and some viruses | Chlamydia trachomatis |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
additional information | - |
additional information | kinetics, overview | Chlamydia trachomatis |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
CDP + thioredoxin | Chlamydia trachomatis | - |
2'-deoxyCDP + thioredoxin disulfide + H2O | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Chlamydia trachomatis | - |
a human pathogen | - |
Oxidation Stability | Organism |
---|---|
the enzyme is not stable to to reactive oxygen and nitrogen species, RO(N)S, produced by the hosts immune system | Chlamydia trachomatis |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
CDP + thioredoxin | - |
Chlamydia trachomatis | 2'-deoxyCDP + thioredoxin disulfide + H2O | - |
? |
Subunits | Comment | Organism |
---|---|---|
tetramer | 2 * R1 subunit + 2 * R2 subunit | Chlamydia trachomatis |
Synonyms | Comment | Organism |
---|---|---|
More | a class Ic ribonucleotide reductase | Chlamydia trachomatis |
RNR | - |
Chlamydia trachomatis |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
22 | - |
assay at | Chlamydia trachomatis |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
manganese-iron cofactor | the class Ic RNR from Chlamydia trachomatis uses a Mn(IV)/Fe(III) cofactor, with high specificity for MnIV, which functionally replaces the tyrosyl radical used by conventional class I RNRs to initiate substrate radical production. The intermediate decays by reduction of the Fe site to the active MnIV/FeIII-R2 complex. The reaction of the MnII/FeII-R2 species with H2O2 proceeds in three resolved steps: sequential oxidation to MnIII/FeIII-R2 and Mn(IV)/Fe(IV)-R2, followed by decay of the intermediate to the active Mn(IV)/Fe(III)-R2 product, kinetics and reaction mechanism, overview | Chlamydia trachomatis | |
thioredoxin | - |
Chlamydia trachomatis |